Rating of pharmacy chains in Russia: Q3 of 2014

12/19/2014

Rating of pharmacy chains in Russia: Q3 of 2014.

Retail pharmacy market increased by 8.5% and amounted to 603 billion rubles for 1-3 quarter in Russia.

The concentration in TOP 15 leading pharmacy chains is growing and takes 24.6% as a result of 1-3 quarters. Also it should be mentioned that this figure is increasing from one quarter to another (the share of TOP-15 pharmacy chains is about 25.4% in Q3). Thus, the share of leading pharmacy chains will reach about 25% (while this indicator was registered at the level of 21%).

The largest turnover growth among TOP-15 was represented by two pharmacy chains Pharmland and Samson-Pharma (32%) in comparison with Q3 2013. Only Pharmaimpex showed a turnover reduction by 3%.

The reason of this increase of concentration indicator was related to mergers of several large pharmacy chains in 2013. This trend was over in 2014.

In August 2014, "A5" and "Pharmaimpex" signed a contract on creating marketing partnership under own brand name "Kompas". It will give an opportunity to conduct mutual activities with drug manufacturers, to get the best terms & conditions of direct contracts and also it will enable to make unified products portfolio under own trade name. It was afterwards found out that A5» started negotiation with Pharmaimpex» about merging. The combined chain will become the leader in the market.

Finnish pharmaceutical company Oriola-KD consider selling its assets in Russia, which include "Stariy lekar" and "03" pharmacies. Prospective customer is pharmacy chain "A.V.E.Group".

Thus, changes in the pharmacy retail goes on and on. Probably, the current disposition of forces will be changed again.

Ranking

Pharmacy Chains

Volume,

billions of

rubles

Share of the Commercial segment,

Turnover increase compared to

Number of stores

Q3 2014

Q3 2013

1

Rigla

6,6

3,3%

23%

1 122

2

Implozia

5,9

2,9%

15%

1 100

3

A.V.E (with "36,6" is included)

5,5

2,7%

1%

612

4

A5

4,7

2,3%

20%

992

5

Doctor Stoletov ( Ozerki is included)

4,5

2,2%

19%

345

6

Raduga (Pervaya Pomosch is included)

4,5

2,2%

10%

794

7

Pharmacor

3,3

1,6%

9%

400

8

Pharmaimpex

2,7

1,3%

-3%

524

9

Pharmland

2,6

1,3%

32%

470

10

Planeta zdorovya

2,2

1,1%

5%

530

11

Vita

2,0

1,0%

7%

475

12

Klassika

1,9

0,9%

12%

172

13

Samson-Pharma

1,7

0,9%

32%

37

14

Ladushka

1,7

0,8%

10%

225

15

Melodia zdorovya

1,5

0,7%

17%

488

 


TOP-15

51,2

25,4%

13,3%

8 133

 

 

Ranking

Pharmacy Chains

Volume,

billions of

rubles

Share of the Commercial segment,

Turnover increase compared to

Number of stores

Q1-Q3 2014

Q1-Q3 2013

1

Rigla

19,2

3,2%

19%

1 122

2

A.V.E (with 36,6» is included)

17,3

2,9%

9%

612

3

Implozia

16,4

2,7%

13%

1 100

4

A5

14,0

2,3%

16%

992

5

Doctor Stoletov ( Ozerki is included)

13,4

2,2%

12%

345

6

Raduga (Pervaya Pomosch is included)

11,8

2,0%

8%

794

7

Pharmaimpex

8,9

1,5%

7%

524

8

Planeta zdorovya

7,3

1,2%

9%

530

9

Pharmland

7,0

1,2%

40%

470

10

Pharmacor

6,8

1,1%

12%

400

11

Klassika

5,9

1,0%

13%

172

12

Vita

5,9

1,0%

6%

475

13

Samson-Pharma

5,2

0,9%

24%

37

14

Ladushka

4,8

0,8%

12%

225

15

Melodia zdorovya

4,5

0,7%

21%

488

 


TOP-15

148,3

24,6%

13,7%

8 286

 

 


Back to the list